Sildenafil Citrate Tablet, Film Coated
Product Images NDC 71335-1437

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 71335-1437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Sildenafil_fig1.jpg (Sildenafil Fig1)
This is a graph showing the change in sitting systolic blood pressure in healthy volunteers over time after taking either a 100mg dose of sildenafil or a placebo. The graph indicates the blood pressure readings at pre-dose, and at 4, 8, 12, 16, and 20 hours post-dose.*
FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Sidenafil_fig_5 (Sildenafil Fig 5)
This is a description of Figure 5 which shows the mean sildenafil plasma concentrations in healthy male volunteers.*
FDA Label Image

Label Image (Lbl713351437)

Label Image (Lbl713351437)
This appears to be a label of a medication bottle containing Sildenafil Citrate tablets in 100mg dosage form. The manufacturer listed is Ajanta Pharma USA Inc. and the medication is a generic version of Viagra. The label provides storage instructions, expiration date, and warns against keeping the medication out of reach of children.*
FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Sildenafil-fig7 (Sildenafil Fig7)
The text provides a graph showing the percentage of patients reporting improvement after taking different tablets including Placebo, Sidenail Tablets 25mg, Sideral Tablets, and Sitdari Tablets. The graph indicates that 100% of patients reported improvement after taking Sitdari, while only 4%, 63%, and 24% of patients reported improvement after taking Placebo, Sidenail Tablets 25mg, and Sideral Tablets, respectively. Therefore, it seems like Sitdari is the most effective tablet, based on the data provided in the text.*
FDA Label Image

Str (Sildenafil Structure)

FDA Label Image

Figure2 (Sildenafil Fig2)

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.